当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析

晨光生物

(300138)

  

流通市值:54.05亿  总市值:65.56亿
流通股本:3.98亿   总股本:4.83亿

晨光生物(300138)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.11亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益338728.70万元,未分配利润213309.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产796032.15万元,负债457303.44万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,047,254,465.573,657,547,726.711,716,472,687.326,994,192,786.23
营业总成本4,718,060,635.453,432,495,143.031,605,425,014.26,868,044,529.72
其他经营收益
营业利润368,695,457.16263,968,367.45129,813,643.12106,035,576.71
利润总额370,346,580.49264,861,158.21131,283,325.59106,945,324.71
净利润311,329,068.45221,253,745.12111,187,387.9477,957,113.49
每股收益
其他综合收益-15,928,224.68-2,914,508.54-807,209.723,336,226.69
综合收益总额295,400,843.77218,339,236.58110,380,178.2281,293,340.18
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,778,547,473.747,112,389,019.288,093,880,839.236,808,992,375.28
非流动资产:
非流动资产合计2,181,773,984.222,186,684,857.882,203,548,131.832,213,528,285.32
资产总计7,960,321,457.969,299,073,877.1610,297,428,971.069,022,520,660.6
流动负债:
流动负债合计4,164,742,425.235,589,174,757.485,762,603,349.894,596,089,600.87
非流动负债:
非流动负债合计408,292,022.14399,673,716.281,269,756,264.051,271,741,880.82
负债合计4,573,034,447.375,988,848,473.767,032,359,613.945,867,831,481.69
所有者权益(或股东权益):
归属于母公司股东权益合计3,334,587,068.133,258,743,076.143,218,162,338.763,109,489,222.5
股东权益合计3,387,287,010.593,310,225,403.43,265,069,357.123,154,689,178.91
负债和股东权益合计7,960,321,457.969,299,073,877.1610,297,428,971.069,022,520,660.6
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计5,505,500,370.14,098,466,852.611,918,596,958.417,878,741,829.31
经营活动现金流出小计3,168,940,641.192,268,730,213.271,388,152,550.448,101,556,789.28
经营活动产生的现金流量净额2,336,559,728.911,829,736,639.34530,444,407.97-222,814,959.97
投资活动产生的现金流量:
投资活动现金流入小计3,620,753,610.681,793,627,155.661,098,489,002.421,060,378,235.15
投资活动现金流出小计3,906,844,695.073,116,472,382.252,575,097,320.261,501,333,221.32
投资活动产生的现金流量净额-286,091,084.39-1,322,845,226.59-1,476,608,317.84-440,954,986.17
筹资活动产生的现金流量:
筹资活动现金流入小计1,789,690,035.91,965,690,035.91,505,278,154.265,783,439,209.46
筹资活动现金流出小计3,018,717,841.51,730,533,463.36335,287,014.635,679,638,840.94
筹资活动产生的现金流量净额-1,229,027,805.6235,156,572.541,169,991,139.63103,800,368.52
汇率变动对现金及现金等价物的影响-4,979,642.25-2,226,398.82-2,338,013.84-10,493,145.08
现金及现金等价物净增加额816,461,196.67739,821,586.47221,489,215.92-570,462,722.7
期末现金及现金等价物余额1,331,263,436.691,254,623,826.49736,291,455.94514,802,240.02
补充资料:
现金及现金等价物的净增加额-739,821,586.47--570,462,722.7
最新报告期:2025-10-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国泰海通林逸丹,王艳君0.760.971.162025-10-29
西南证券朱会振,杜雨聪0.791.031.332025-10-28
浙商证券钟烨晨0.730.941.142025-10-27
华鑫证券张倩,孙山山0.761.011.172025-10-27
申万宏源吕昌0.670.841.062025-10-25
TOP↑